Registration number:
Unaudited Abbreviated Accounts
for the Year Ended
Medeor Pharma Limited
Contents
|
|||
|
Medeor Pharma Limited
(Registration number: 05938602)
Abbreviated Balance Sheet at 30 September 2015
Note |
2015
|
2014
|
|||||||
Fixed assets |
|||||||||
Tangible fixed assets |
|
|
|||||||
Current assets |
|||||||||
Debtors |
|
|
|||||||
Cash at bank and in hand |
|
|
|||||||
|
|
||||||||
Creditors: Amounts falling due within one year |
( |
( |
|||||||
Net current liabilities |
( |
( |
|||||||
Total assets less current liabilities |
( |
( |
|||||||
Provisions for liabilities |
( |
( |
|||||||
Net liabilities |
( |
( |
|||||||
Capital and reserves |
|||||||||
Called up share capital |
|
|
|||||||
Profit and loss account |
( |
( |
|||||||
Shareholders' deficit |
( |
( |
Approved by the director on
.........................................
Dr D J Tapolczay
Director
1
Medeor Pharma Limited
Notes to the Abbreviated Accounts for the Year Ended 30 September 2015
......... continued
Accounting policies |
Basis of preparation
Going concern
At the balance sheet date, the company's liabilities exceeded its assets. The company has received assurance from the director that he will continue to give financial support to the company by way of a directors' loan for twelve months from the date of signing these financial statements.
On this basis, the director considers it appropriate to prepare the accounts on a going concern basis. However, should the financial support mentioned above not be forthcoming, the going concern basis used in preparing the company's accounts may be invalid and adjustments would have to be made to reduce the value of assets to their realisable amount and to provide for any further liabilities which might arise. The accounts do not include any adjustment to the company's assets or liabilities that might be necessary should this basis not continue to be appropriate.
Depreciation
Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows:
Asset class |
Depreciation method and rate |
Fixtures and Fixings |
|
Computer Equipment |
|
Deferred tax
Financial instruments
Medeor Pharma Limited
Notes to the Abbreviated Accounts for the Year Ended 30 September 2015
......... continued
Fixed assets |
Tangible assets
|
Total
|
|||||
Cost |
||||||
At 1 October 2014 |
4,317 |
4,317 |
||||
At 30 September 2015 |
4,317 |
4,317 |
||||
Depreciation |
||||||
At 1 October 2014 |
3,667 |
3,667 |
||||
Charge for the year |
293 |
293 |
||||
At 30 September 2015 |
3,960 |
3,960 |
||||
Net book value |
||||||
At 30 September 2015 |
|
|
||||
At 30 September 2014 |
|
|
Share capital |
Allotted, called up and fully paid shares
2015 |
2014 |
|||||||||||
No. |
£ |
No. |
£ |
|||||||||
|
|
|
|
|
||||||||